RxDoctor Payments Data

Jason Rose, MD

Anesthesiology · Washington, DCNPI 1407896343

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Merck at 32.5% of the total. Reporting peaked in 2019 at $183 and has fallen 88.2% since, to $22 in 2025.

$582in general payments, 2019–2025

Across 30 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$189
  • Avanos Medical$82
  • Mallinckrodt Hospital Products Inc.$74
  • Mallinckrodt Enterprises LLC$64
  • Eagle Pharmaceuticals, Inc.$41
  • Acacia Pharma Inc$36
  • plus $96 from 5 others

What the payments were for

  • Food & beverage$582100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$582 in reported general payments places this provider in the 85th percentile of 253 anesthesiology providers in District of Columbia.

See all anesthesiology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$74,309
Medicare patients
180
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →